Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Official siteFINANCIAL SERVICES • SHELL COMPANIES • NASDAQ
Market Cap: $264.62M
Last updated: Nov 17, 2026 at 10:25 AM ET
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Competitors
The companies most similar to Drugs Made In America Acquisition Corp. Ordinary Shares are Digital Asset Acquisition (DAAQ), Yorkville Acquisition (MCGA) and Roman DBDR Acquisition Corp. II Ordinary shares (DRDB). Drugs Made In America Acquisition Corp. Ordinary Shares trades at 58.6x earnings, against a median of 49.6x for the 11 of these companies with a P/E. By market cap, Drugs Made In America Acquisition Corp. Ordinary Shares ranks 8th of the 13 companies on this page; Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares (ANSC) is the largest at $476.13M.
Peer Comparison
DMAA's ROIC of 29.5% is above the peer median of 9.5%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
Similar Companies
These are the 12 companies most similar to Drugs Made In America Acquisition Corp. Ordinary Shares, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Shell Companies.
| Company | About | Peers |
|---|---|---|
| Digital Asset Acquisition Corp. (DAAQ) | Digital Asset Acquisition Corp. The company is headquartered in Princeton, New Jersey. | DAAQ competitors |
| Yorkville Acquisition Corp. (MCGA) | MCGA, in partnership with Yorkville Acquisition Corp., is a forward-thinking technology firm focused on enhancing operational efficiency across diverse... | MCGA competitors |
| Roman DBDR Acquisition Corp. II Ordinary shares (DRDB) | Roman DBDR Acquisition Corp. II (Ticker: DRDB) is a special purpose acquisition company (SPAC) focused on merging with innovative... | DRDB competitors |
| RF Acquisition Corp II Ordinary Shares (RFAI) | RF Acquisition Corp II (RFAI) is a publicly traded special purpose acquisition company (SPAC) dedicated to partnering with high-growth businesses across... | RFAI competitors |
| SIM Acquisition Corp. I Unit (SIMAU) | SIM Acquisition Corp. I Unit is a special purpose acquisition company (SPAC) targeting high-growth enterprises, primarily within the technology sector. | SIMAU competitors |
| GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT) | GP-Act III Acquisition Corp. (GPAT) is a dynamic special purpose acquisition company (SPAC) with a strategic focus on identifying and acquiring high-growth... | GPAT competitors |
| New Providence Acquisition Corp. III Class A Ordinary Shares (NPAC) | New Providence Acquisition Corp. III (NPAC) is a special purpose acquisition company (SPAC) focused on merging with innovative growth enterprises... | NPAC competitors |
| Siddhi Acquisition Corp Class A Common stock (SDHI) | Siddhi Acquisition Corp focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase... | SDHI competitors |
| Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares (ANSC) | Agriculture & Natural Solutions Acquisition Corporation focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase... | |
| Fifth Era Acquisition Corp I Class A Ordinary Shares (FERA) | Fifth Era Acquisition Corp I focuses on entering a merger, amalgamation, share exchange, asset acquisition, share purchase... | FERA competitors |
| Archimedes Tech SPAC Partners II Co. Ordinary Shares (ATII) | Archimedes Tech SPAC Partners II Co. (ATII) is a special purpose acquisition company (SPAC) focused on merging with high-growth technology firms that present... | |
| Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) | Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on identifying and merging with transformative businesses... | OACC competitors |
Frequently Asked Questions About DMAA
Who are Drugs Made In America Acquisition Corp. Ordinary Shares' main competitors?
The companies most similar to Drugs Made In America Acquisition Corp. Ordinary Shares include Digital Asset Acquisition (DAAQ), Yorkville Acquisition (MCGA), Roman DBDR Acquisition Corp. II Ordinary shares (DRDB), RF Acquisition Corp II Ordinary Shares (RFAI) and SIM Acquisition Corp. I Unit (SIMAU), listed from the closest match.
Who is Drugs Made In America Acquisition Corp. Ordinary Shares' biggest competitor?
Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares (ANSC) is the largest of the similar companies at $476.13M; Digital Asset Acquisition (DAAQ) is the closest match by business profile, size, sector and industry.
How does DMAA stock compare with its competitors?
DMAA's P/E is 58.6x against a peer median of 49.6x; its net margin is 0.0% against a peer median of 0.0%.
Which of Drugs Made In America Acquisition Corp. Ordinary Shares' competitors pays a higher dividend?
Drugs Made In America Acquisition Corp. Ordinary Shares pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Drugs Made In America Acquisition Corp. Ordinary Shares bigger than its competitors?
No. Drugs Made In America Acquisition Corp. Ordinary Shares is 8th by market cap among the 13 companies on this page; the largest is Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares (ANSC) at $476.13M.
DMAA pages: Overview, Competitors